Teenager missing from Swansea may have gone to city centre
The newly approved medication, ublituximab, is given through an intravenous (IV) infusion and used to help treat relapses of MS.
Compared to other treatments, the drug can be given much faster through an IV infusion, allowing more patients to be treated sooner.
MS, a lifelong condition, happens when a person's immune system attacks their brain and spinal cord.
The immune system creates cells that attack and kill viruses in the body but for those with MS, the cells attack the nerves instead.
This week, Monday 28th April to Sunday 4th May marks MS Awareness Week.
Fiona Creelie, from Milford Haven, was the first patient to be treated with the new drug at the Jill Rowe Neurology Ambulatory Unit at Morriston Hospital in Swansea.
'I started experiencing pins and needles and sharp shooting pains in my face in September,' the 35-year-old said.
'They initially thought it was trigeminal neuralgia, which is sudden, severe facial pain.
'In November, I started to get the same sensations down my right arm, so I went to A&E and had an MRI scan and lots of other tests and then was referred to Morriston Hospital.'
The mum-of-one only officially received her diagnosis of MS and just two weeks later received her first IV treatment of the new drug.
Fiona added: 'I was offered a selection of three drugs, but I picked this one because it fitted in with our family life.
'This treatment will be once every six months for just an hour each time, so it was the best fit for me.
'It's a bit crazy to have been the first person to receive the treatment but it's also really exciting.'
With the new treatment able to be given much quicker, it will help to reduce the time patients wait for treatment.
Dr Owen Pearson, consultant neurologist at Morriston Hospital, said: 'The drug itself is a new version of an already approved drug, but the advantage is that it's given faster, through an IV infusion.
'It allows us to treat more patients per day and that allows us to shorten the waiting time for treatment.
'It is a highly effective treatment which helps to stop focal inflammation, which is new lesions appearing on an MRI, or having new relapses of MS.
'The unit was starting to operate above capacity so the introduction of this drug will help with that.
'Clinical trials for the drug were done in other centres in the UK, including Cardiff, and it has recently been approved for use on the NHS.
'Being able to offer it so quickly to our patients in Swansea Bay involves a lot of working together with the pharmacy department.
'We have a dedicated clinical pharmacist within our team which allows us to deliver new treatments like this to our patients.'
Charles-Henry Her, the team's clinical pharmacist, added: 'The consultants are really proactive in finding out about these new drugs and then they provide me with all of the information I need.
'I learn about the new drugs and how they work and make sure our systems are ready for us to introduce them.'
Around 2,200 MS patients are supported in Swansea Bay, with the service seeing patients from Machynlleth, in Powys, right across to Cowbridge, in the Vale of Glamorgan.
Dr Gillian Ingram, consultant neurologist, said: 'The fact that the treatment is much shorter will allow more MS patients to come through.
'It is also beneficial for patients to have a choice of treatment, so they can choose the option that's right for them.
'There are always new developments in treatments for MS and it is really nice to keep Wales at the forefront of that.'
Alexandra Strong, Jill Rowe Neurology Ambulatory Unit manager, said: 'It is exciting for both patients and our unit to have another treatment available for MS, and it was exciting for us to be the first to give the treatment in the NHS.
'It is another option for patients to help improve their treatment and health.
'It will allow more flexibility for patients as it will make it much easier to fit in with their lifestyle, while it will also allow us to be more flexible with the treatment we can offer too.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
23 minutes ago
- Daily Record
SNP Government 'failing stroke patients' as average treatment waiting time over two hours
Figures obtained by Scottish Labour revealed that patients are now waiting nearly ten minutes longer for blood clots to be removed than they were in 2018. The SNP has been accused of "letting the clock run down on stroke patients" after average waits for treatment racked up to more than two hours. Figures obtained by Scottish Labour revealed that patients are now waiting nearly ten minutes longer for blood clots to be removed than they were in 2018. Removing blood clots quickly gives stroke patients a higher chance of recovery — so delays can mean the difference between years of living independently, or severe disability or death. But the time it takes from calling an ambulance to receiving the treatment to remove the blood clot, known as thrombolysis, has risen to 126 minutes. Patients in the remotest areas face waits of more than 30 minutes longer than the fastest urban health board. Scottish Labour's Health Spokesperson Jackie Baillie said: "These figures are a stark reminder that under the SNP stroke patients face a postcode lottery. "Modern technology has the potential to transform the lives of stroke survivors, yet after nearly two decades in power the SNP can't keep up with services elsewhere. "The SNP is letting the clock run down on stroke patients — Scottish Labour will invest in our NHS and ensure patients get the treatment they need." Overall, the proportion of stroke patients receiving clot-busting thrombolysis within 30 minutes fell in half of the 14 health boards. No patients in the Borders, Shetland, Orkney, or the Western Isles received thrombolysis in 2024, compared to more than a quarter in Tayside and Forth Valley. In the Borders, patients faced on average two and a half hours' wait between calling an ambulance and receiving thrombolysis. The average wait in Orkney, Shetland and the Western Isles was also over two and a half hours. The figure for Highland was two hours and 25 minutes, while Dumfries and Galloway was two hours and 22 minutes. More urban health boards had much shorter waiting times. The shortest was Forth Valley, which was one hour and 55 minutes. In NHS Lothian, the waiting time was one hour 58 minutes. Tayside was two hours and one minute, while Ayrshire & Arran and Fife were both two hours and two minutes. The figures come as stroke charities urged the SNP Government to provide a 24/7 service for thrombectomies. This is a procedure for quickly removing blood clots that is offered round the clock in England but is not available anywhere in Scotland after 9pm. This means that for 11 of every 24 hours, people suffering a stroke have no immediate option of a thrombectomy. The Scottish Government was approached for comment.
Daily Record
23 minutes ago
- Daily Record
Scotland's NHS in dire state as delays are matter of life or death
Record View says the SNP needs to sort out our NHS, particularly when it comes to stroke patients for whom time is of the essence. Scotland's NHS is in a dire state. One in six Scots are languishing on a waiting list, with many using private healthcare to get treatment. It can be nearly impossible to see a GP, with far too many people phoning up at 8am to find out all appointments for the day are gone. Many of our hospital buildings are crumbling and in dire need of repair. And now it has been revealed that stroke patients are waiting longer on average for treatment than they were seven years ago. The share of stroke patients receiving treatment within half an hour has also fallen in half of Scotland's health boards. This is very concerning. Removing blood quickly has a big impact on the chances of recovery from a stroke. The time it takes to do so can be the difference between an independent life, suffering a severe disability or death. It is particularly worrying that the situation is worse in rural areas – with some average waits at two-and-a-half hours. People should not need to live in our cities to receive the best medical treatment. The SNP needs to sort out our NHS, particularly when it comes to stroke patients for whom time is of the essence. It is an issue which is affecting the lives of ordinary Scots more and more each day. And the situation doesn't seem to be getting any better. If they don't make improvements before May next year, it may come to hurt the SNP when people are casting their votes. Group stages Keir Starmer and other European leaders will join Volodmy Zelensky in Washington DC tomorrow for a meeting with Donald Trump. It comes at a crunch time, as the US President recently met Vladmir Putin in Alaska – but didn't manage to agree a ceasefire deal. Starmer and other European leaders need to force Trump to realise that Ukraine has to be a central part of a peace deal with Russia. Agreeing to take territory away from Ukraine without Zelensky being at the negotiating table would be unacceptable. The PM has had some success in dealing with Trump and he has been strong in his support for Ukraine. His previous visit to the White House seemed to go well and he managed to negotiate a trade deal. We hope there is not a repeat of Zelensky's previous time across the pond, where Trump and JD Vance berated him on live TV.
South Wales Guardian
3 hours ago
- South Wales Guardian
More checks, tests and scans to be offered out of hours at local health centres
Extending the opening hours for Community Diagnostic Centres (CDCs) is increasing access to health services and speeding up diagnosis for thousands of patients, according to the Department of Health and Social Care (DHSC) Some 7.2 million CDC tests and scans have been delivered since July 2024. Shopping centres, community hospitals and university campuses are among the venues closer to people's homes where the centres are based and open out of hours for health appointments. Health Secretary Wes Streeting said the Government is 'determined to offer healthcare that fits around working people's lives and not the other way around'. He added: 'From early morning MRI scans to late evening blood tests, we're meeting patients where they need it most by extending the operating hours for community diagnostic centres and putting patients first.' The NHS delivered more than 1.6 million more tests and scans from July 2024 to June 2025 and there were 218,463 people who had cancer ruled out or diagnosed within 28 days, the DHSC said. Improved performance on the faster diagnosis standard means that nearly 97,000 more people had cancer diagnosed or ruled out within 28 days between July 2024 and June 2025, compared to the same period last year. At Oldham CDC in Greater Manchester, extended opening hours have cut lung cancer diagnosis times from 42 days to just 18.8 days, while Queen Victoria Hospital CDC in East Grinstead, West Sussex, is recording five times more respiratory patient interactions per session, with 92% avoiding the need for hospital outpatient appointments. Patients can be referred to CDCs through their GP or hospital-based clinical teams. Mr Streeting said the Government's 10-year health plan is 'revolutionising how healthcare works' and the measures are helping to bring care closer to the community. Professor Meghana Pandit, NHS England national medical director, said: 'We know people are living incredibly busy lives and it's vital NHS care reflects that. 'The services provided by Community Diagnostics Centres enable people to receive the all-clear or a diagnosis at a time and location that suits them, whether before a school drop off or after a work shift, and extending their opening hours means more people are being seen more quickly.' CDCs can provide a range of tests including MRI and CT scans, echocardiography and phlebotomy services. Wayne Rowlands, who visited the Norfolk and Norwich University Hospital Community Diagnostic Centre for an emergency CT scan, described it as a 'pleasant experience' in a setting that was 'very bright and not at all like a hospital'. The Government's plan for change is backed by more than £6 billion of additional capital investment to improve capacity for elective, diagnostic, and urgent care services over five years, with more than £600 million capital funding committed for 2025/26 to transform diagnostic services. This includes funding up to five additional CDCs in 2025/26 and extending opening hours for all CDCs at evenings and at weekends. Laura Challinor from the Blood Cancer UK charity welcomed the move but said more must be done to tackle regional variation and speed up testing. She said: 'It's imperative that everyone affected by blood cancer can readily access the diagnostic tests and appointments they need. 'With blood cancer being the UK's third biggest cancer killer and survival lagging behind countries of similar wealth and health, doing all we can to turn that tide is critical.'
